How can imaging biomarkers enhance our understanding of MS? Dr Anne Cross and Dr Matthew Brier examine MRI advancements that provide new insights into diagnosis, progression, and treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002607. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Multiple Sclerosis https://emedicine.medscape.com/article/1146199-overview Emerging MRI Biomarkers for the Diagnosis of Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/39511991/ Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/38079177/ Biomarkers for Diagnosis and Prognosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: Review Article https://pubmed.ncbi.nlm.nih.gov/40547008/ Update on Neuromyelitis Optica Spectrum Disorder https://pmc.ncbi.nlm.nih.gov/articles/PMC7771018/ Sjogren Syndrome https://emedicine.medscape.com/article/332125-overview Detection of Multiple Sclerosis Lesions by Susceptibility-Weighted Imaging: A Systematic Review and Meta-Analyses https://pubmed.ncbi.nlm.nih.gov/39406601/ The Central Vein Sign on T2*-Weighted Images as a Diagnostic Tool in Multiple Sclerosis: A Systematic Review and Meta-Analysis Using Individual Patient Data https://pubmed.ncbi.nlm.nih.gov/31796822/ Paramagnetic Rim Lesions Are Highly Specific for Multiple Sclerosis in Real-World Data https://pubmed.ncbi.nlm.nih.gov/39371137/ Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics https://pubmed.ncbi.nlm.nih.gov/30385472/ Slowly Expanding Lesions Are Associated With Disease Activity and Gray Matter Loss in Relapse-Onset Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/39390692/ TSPO PET in Multiple Sclerosis: Emerging Insights Into Pathophysiology, Prognosis, and Treatment Monitoring https://pubmed.ncbi.nlm.nih.gov/40450829/ An Update on the Use of Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Relapsing Multiple Sclerosis https://pubmed.ncbi.nlm.nih.gov/36946625/

Ver todos los episodios